Aprea Therapeutics
(NASDAQ) APRE
Aprea Therapeutics Financials at a Glance
Market Cap
$8.37M
Revenue (TTM)
$285.76K
Net Income (TTM)
$12.60M
EPS (TTM)
$-1.97
P/E Ratio
-0.37
Dividend
$0.00
Beta (Volatility)
-0.81 (Low)
Dividend
$0.00
Beta (Volatility)
-0.81 (Low)
Price
$0.76
Volume
41,542
Open
$0.73
Price
$0.76
Volume
41,542
Open
$0.73
Previous Close
$0.76
Daily Range
$0.73 - $0.78
52-Week Range
$0.55 - $2.65
Dividend
$0.00
Beta (Volatility)
-0.81 (Low)
Price
$0.76
Volume
41,542
Open
$0.73
Previous Close
$0.76
Daily Range
$0.73 - $0.78
52-Week Range
$0.55 - $2.65
APRE News
APRE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aprea Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Oren Gilad, PhD
Website
www.aprea.comHeadquarters
Boston, MA 02116, US
APRE Financials
Key Financial Metrics (TTM)
Gross Margin
-14%
Operating Margin
-46%
Net Income Margin
-44%
Return on Equity
-75%
Return on Capital
-1%
Return on Assets
-79%
Earnings Yield
-2.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.37M
Shares Outstanding
11.45M
Volume
41.54K
Short Interest
0.00%
Avg. Volume
2.17M
Financials (TTM)
Gross Profit
$264.04K
Operating Income
$13.23M
EBITDA
$13.23M
Operating Cash Flow
$12.89M
Capital Expenditure
$0.00
Free Cash Flow
$12.89M
Cash & ST Invst.
$14.60M
Total Debt
$0.00
Aprea Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.34K
-98.4%
Gross Profit
$2.09K
+99.9%
Gross Margin
-62.69%
N/A
Market Cap
$8.37M
N/A
Market Cap/Employee
$1.05M
N/A
Employees
8
N/A
Net Income
$2.46M
+15.2%
EBITDA
$2.64M
+18.1%
Quarterly Fundamentals
Net Cash
$14.60M
-36.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-79.08%
N/A
Return on Invested Capital
-1.00%
N/A
Free Cash Flow
$3.07M
+12.6%
Operating Cash Flow
$3.07M
+12.6%